← Back to Search

Continuous Glucose Monitoring for Diabetes (GOOD-ER Trial)

N/A
Waitlist Available
Led By Mark J O'Connor, MD
Research Sponsored by Mark O'Connor
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

GOOD-ER Trial Summary

This trial found that people with type 1 or type 2 diabetes who used a continuous glucose monitor were less likely to have repeat emergency room visits and felt less distressed about managing their diabetes.

Who is the study for?
This trial is for English or Spanish-speaking adults with type 1 or type 2 diabetes who have visited the emergency room due to very high or low blood sugar. They should not be current users of continuous glucose monitors, pregnant, mentally impaired, prisoners, require hospital admission, nor have upcoming CT/MRI scans.Check my eligibility
What is being tested?
The study tests if using a continuous glucose monitor after leaving the emergency room helps people with diabetes avoid more ER visits and better manage their blood sugar levels while reducing stress about their condition.See study design
What are the potential side effects?
Continuous glucose monitoring generally has minimal side effects but may include skin irritation at the sensor site. Care coordination involves regular communication with healthcare providers which typically does not cause direct physical side effects.

GOOD-ER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Diabetes Distress
Change in the Problem Areas in Diabetes Score
Outpatient Clinic Attendance Rate
Secondary outcome measures
Change in Hemoglobin A1c
Number of Patients With Repeat Emergency Utilization
Number of Sensor Checks Per Day
+3 more

GOOD-ER Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Continuous Glucose MonitoringExperimental Treatment2 Interventions
Group II: Care CoordinationActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous Glucose Monitoring
2023
Completed Phase 2
~1000

Find a Location

Who is running the clinical trial?

Mark O'ConnorLead Sponsor
Mark J O'Connor, MDPrincipal InvestigatorUniversity of Massachusetts, Worcester

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary objective of this experiment?

"This clinical trial is mainly assessing the impact of diabetes distress through periodic follow-up visits, usually within a fortnight or three weeks. Secondary markers being studied include number of participants with repeated emergency room utilization, outpatient appointments where CGM data was used to alter management strategies, and hemoglobin A1c levels."

Answered by AI

How many participants can enroll in this clinical trial?

"Affirmative, according to clinicaltrials.gov this research endeavour is actively seeking volunteers. The initial posting was on May 1st 2022 and the details were most recently edited on the same day; it calls for 200 individuals from a single site."

Answered by AI

Are there still vacancies for participants in this research project?

"Affirmatively, the information on clinicaltrials.gov shows that this research project is actively seeking participants. The initial posting was made on 5th January 2022 and it has been recently updated as of 1st May 2022."

Answered by AI

Who else is applying?

What site did they apply to?
UMass Memorial Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Glycemic Optimization On Discharge From the Emergency Room
Mark O'Connor 2022. "Glycemic Optimization On Discharge From the Emergency Room". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05197829.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top